483 GlaxoSmithKline Biologicals Jun 2006

483 GlaxoSmithKline Biologicals Jun 2006

Rose Ashley FDA, Paula Trost FDA$119.00 - Available Now

FDA investigators audited the GlaxoSmithKline Biologicals - Dresden, Germany facility and issued inspectional observations (via FDA 483) on 22 Jun 2006.

Product details

  • Category: Biologics
  • Inspection end: 22 Jun 2006
  • Location: Dresden, Germany
  • FEI: 3004835618
Add To Cart